Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiolabeled BC8 Combined With Cyclophosphamide and TBI for Advanced ALL
NCT00003870Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Feb 1999
- Primary completion
- Nov 2001
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of apamistamab in acute lymphoblastic leukemia (ALL), sponsored by Fred Hutchinson Cancer Center. Started Feb 1999; status: completed.
02
Drugs
apamistamab
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00003870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003870.